Financings In Brief
This article was originally published in The Gray Sheet
Integrated Diagnostics debuts with $30 million funding: Start-up diagnostics developer debuts with the support of a $30 million "Series A" financing round, led by InterWest Partners. The Seattle firm is developing genomic and proteomic technologies to identify organ-specific proteins and enable the diagnosis and prognosis of a variety of diseases. Areas of focus include personalized and preventive diagnostics for cancer, diabetes and Alzheimer's disease. "Integrated Diagnostics' research enabling technologies will allow us to cut in half the standard development times for diagnostics," said company founder Leroy Hood. Launched Oct. 14, Integrated Diagnostics is an outgrowth of a public-private partnership between the nation of Luxembourg and several American research institutions, including the Institute for Systems Biology. Hood is the current president of ISB, inventor of the DNA sequencer, and previous founder of more than a dozen biotech firms, including Amgen and Applied Biosystems
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.